Curanex Pharmaceuticals Inc (CURX)
CURX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.88
0.00% on the day
Market cap
$7.7M
Nano cap
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CURX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0002025942 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials
Recent IPO: no annual report filed yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-08-26 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-04 |
Source: SEC EDGAR submissions feed, 63 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CALC | CalciMedica Inc. | $1.12 | -7.05% | $7.6M |
| TCRT | Alaunos Therapeutics Inc. | $3.03 | +188.57% | $7.7M |
| APRE | Aprea Therapeutics Inc. | $0.6000 | +1.16% | $7.6M |
| XCUR | Exicure Inc. | $1.15 | +5.50% | $7.5M |
| CNSP | CNS Pharmaceuticals Inc. | $5.35 | +3.08% | $7.8M |
| INM | InMed Pharmaceuticals Inc. Common Shares | $1.33 | -2.21% | $7.3M |
| SNGX | Soligenix Inc. | $0.3348 | -4.80% | $7.3M |
| APUS | Apimeds Pharmaceuticals US Inc. | $4.62 | -11.15% | $7.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier